Date: 2016-09-13
Type of information: Company acquisition
Acquired company: InterHealth Nutraceuticals (USA - CA)
Acquiring company: Lonza (Switzerland)
Amount: up to $ 300 million
Terms: * On September 13, 2016, Lonza announced that it has closed the acquisition of InterHealth Nutraceuticals, a leader in research, development, manufacture and marketing of proprietary, value-added nutritional ingredients for use in dietary supplements, based in Benicia, CA (USA) from Kainos Capital. The InterHealth business will become part of Lonza’s Consumer Care Business Unit, but will retain its facilities and employees. The combination of the two businesses allows Lonza to offer InterHealth’s more than 15 branded ingredients, including its cornerstone ingredient, UC-II, which is revolutionizing the joint-health segment. Lonza acquired InterHealth for a total transaction price of up to USD 300 million split into an upfront payment and an earn-out payment. The transaction is expected to be immediately accretive to Lonza’s earnings.
* On August 15, 2016, Lonza announced that it has agreed to acquire InterHealth Nutraceuticals. Lonza will acquire InterHealth for a total transaction price of up to $ 300 million, representing a multiple of approximately ten times InterHealth’s EBITDA for the twelve months ended July 2016, split into an upfront payment and an earn-out payment. Closing is expected to take place in September 2016 following customary closing conditions.
Details: InterHealth researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. The company offers more than 15 branded ingredients, including its cornerstone ingredient, UC-II® for addressing joint discomfort. The company's products also include Super CitriMax®, a weight loss and satiety ingredient; Meratrim® for weight management; Relora® for stress management; ChromeMate® and Zychrome® for blood sugar and insulin control; and CardiaSlim® for healthy cholesterol support. In addition, InterHealth offers 7-Keto®, Sytrinol®, LOWAT®, Aller-7®, OptiBerry®, L-OptiZinc®, Protykin® and ZMA®. This portfolio complements Lonza’s existing nutritional portfolio in the area of sports nutrition, weight management, immune health and pet health. The acquisition will also expand Lonza’s offerings into new areas such as cognitive and diabetic health.
Related: Nutrition Nutraceuticals
